Question 340
A medical device integration project lists intended inspection meetings but has no evidence that individual interfaces actually passed agreed checks. Which ongoing control would best prevent this failure from recurring?
Explanation
Correct Answer
Audit the use of agreed methods and refresh the quality approach when technologies or product risks change. It is appropriate because quality planning establishes how quality will be achieved and checked; quality control supplies evidence of actual conformance of products. The recurring failure risk is illustrated by: A medical device integration project lists intended inspection meetings but has no evidence that individual interfaces actually passed agreed checks.
Incorrect Answers
This repeating check is mainly concerned with resolve failed quality criteria before acceptance, not with the recurring weakness described here: A medical device integration project lists intended inspection meetings but has no evidence that individual interfaces actually passed agreed checks. The useful ongoing safeguard in this situation is to audit the use of agreed methods and refresh the quality approach when technologies or product risks change.
This repeating check is mainly concerned with maintain the quality register, not with the recurring weakness described here: A medical device integration project lists intended inspection meetings but has no evidence that individual interfaces actually passed agreed checks. The useful ongoing safeguard in this situation is to audit the use of agreed methods and refresh the quality approach when technologies or product risks change.
This repeating check is mainly concerned with product register and configuration identification, not with the recurring weakness described here: A medical device integration project lists intended inspection meetings but has no evidence that individual interfaces actually passed agreed checks. The useful ongoing safeguard in this situation is to audit the use of agreed methods and refresh the quality approach when technologies or product risks change.